---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037027"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-09-18T23:59:59+00:00"
generated_at: "2026-05-31T03:55:46.805176+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience amends merger with NAYA; extends deadline to Oct 14, revised consideration

## Summary
- NAYA purchased 27,500 Series A preferred shares for $137,500 on Sept 16, 2024 per Securities Purchase Agreement.
- NAYA may buy up to additional 72,500 Series A shares for $362,500 before or at closing; prior breaches waived.
- Revised merger consideration: ≤19.9% of INVO common stock pre-merger plus new Series C convertible preferred.
- After stockholder approval, Series C converts to common representing ~60.1% of INVO outstanding shares.
- NAYA to transfer 85% of common stock payment shares to secured lender Five Narrow Lane LP.

## SEC filing metadata
- accession: 0001493152-24-037027
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-09-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224037027/0001493152-24-037027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224037027/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037027
- JSON: https://secwatch.observer/filing/0001493152-24-037027.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.